Fundraising Fox
🦊/Companies
Sign in

ExThera Medical

Martinez, US · Delaware corporation · 2 known investors

Find your way into ExThera Medical

505 people in our graph share verified history with the ExThera Medical team — schools, employers, funds. One of them is your warm intro.

Kesha Cashunlockedknows Keith McCrea · together at University of California, Berkeley (overlapped)
×7knows the team · via University of California, Berkeley
×3knows the team · via D'Amore-McKim School of Business at Northeastern University
knows the team · via University of Massachusetts Lowell
BiotechHealthtechMedical Devices

Founders & leadership

MDMichael DiMeo
Michael DiMeoinChief Financial OfficerMichael DiMeo is an executive with over 20 years of experience in strategic finance and operations within biotechnology and life sciences companies. He has led cross-functional teams across multiple countries and worked on commercial excellence, financial planning, and business transformation initiatives in diagnostics and innovation-driven environments.
EBErin Borger
Erin BorgerinCEO2023–2026Erin Borger previously served as Chief Executive of ExThera Medical, which develops extracorporeal blood filtration devices for removing pathogens from the bloodstream. He brings over 20 years of finance experience from roles at Morgan Stanley and UBS Financial Services, where he reached Managing Director and Market Head.
RSRobert S. Ward
Robert S. WardinExecutiveRobert S. Ward is an executive officer and director at ExThera Medical. He has spent his career developing biomedical polymers for medical devices including cardiac assist systems, glucose sensors, orthopedic implants, and blood filters, and holds numerous patents in the field.
KMKeith McCrea
Keith McCreainVice President of Research and Development, and Chief Science OfficerKeith McCrea holds a PhD in Physical Chemistry from UC Berkeley and has over 20 years of experience in medical device development, with expertise in materials science and polymer science. He is Chief Science Officer and VP of Research and Development at ExThera Medical and President of Stavro Medical.
GP
George PitarraExecutive
KW
Kathleen WhiteinExecutive

Board

JP
John PrestonBoard director
JF
John FeikBoard director
JP
Jacqueline PriceBoard director
LC
Lakhmir ChawlaBoard director
EJ
Eber JaquesBoard director

Investors · 2

Cycad Group LLCSanta Barbara
Fresenius Medical Care VenturesBad Homburg

Reported raises · per SEC filings

Form D private placements

$62.8M disclosed across 6 rounds · 2012–2024

▶$1.5MraisedSep 2024 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael DiMeoExecutive Officer
  • Erin BorgerExecutive Officer, Director
  • Jacqueline PriceDirector
  • John PrestonDirector
  • Robert S. WardExecutive Officer, Director
  • Lakhmir ChawlaDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedSep 2021 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert S. WardExecutive Officer, Director
  • Lakhmir ChawlaDirector
  • Michael BenjaminExecutive Officer
  • Greg DollarhydeDirector
  • Erin BorgerDirector
  • John PrestonDirector
Offering amount
$20M
Amount sold
$6.7M
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.6MraisedMar 2021 · 66 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert S. WardExecutive Officer, Director
  • John PrestonDirector
  • Lakhmir ChawlaExecutive Officer, Director
  • Michael PorterDirector
  • Greg DollarhydeDirector
Offering amount
$20.6M
Amount sold
$20.6M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedMay 2016 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathleen WhiteExecutive Officer
  • John FeikDirector
  • George PitarraExecutive Officer, Director
  • Eber JaquesDirector
  • Robert WardExecutive Officer, Director
  • Keith McCreaExecutive Officer, Director
Offering amount
$7M
Amount sold
$6.7M
Minimum investment
$20K
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3MraisedMay 2016 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith McCreaExecutive Officer, Director
  • Eber JaquesDirector
  • George PitarraExecutive Officer, Director
  • Robert WardExecutive Officer, Director
  • Kathleen WhiteExecutive Officer
  • John FeikDirector
Offering amount
$15.4M
Amount sold
$15.3M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedMay 2016 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith McCreaExecutive Officer, Director
  • Kathleen WhiteExecutive Officer
  • George PitarraExecutive Officer, Director
  • Robert WardExecutive Officer, Director
  • John FeikDirector
  • Eber JaquesDirector
Offering amount
$12.5M
Amount sold
$12M
First sale
Apr 2012
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
AltaThera Pharmaceuticals14 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
SonoThera13 shared keywordsSonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way. The company works on genetic medicine, aiming to address limitations in delivery, safety, durability, and cost.
RayThera13 shared keywordsRayThera develops small molecule therapies targeting unmet needs in immunology. The company focuses on drug discovery in the biotechnology and immunology space.
Carthera10 shared keywordsCarthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.

Companies competing with ExThera Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

ExThera Medical Announces Resolution of Federal Investigation | Press Releases | napavalleyregister.comnapavalleyregister.com · Mar 2026District of Massachusetts | Chief Regulatory Officer for ExThera Medical Charged with Concealing Adverse Events, Including Deaths, from FDA; ExThera Medical Corporation Resolves Investigation | United States Department of Justicejustice.gov · Mar 2026Investors | ExTheraextheramedical.com

Frequently asked questions

Who are ExThera Medical's investors?
ExThera Medical's investors include Cycad Group LLC, Fresenius Medical Care Ventures.
How much funding has ExThera Medical raised?
ExThera Medical has disclosed $62.8M raised across 6 rounds.
Where is ExThera Medical headquartered?
ExThera Medical is headquartered in Martinez, US.